A novel psychiatric scale developed by colleagues of Gedeon Richter Plc. in collaboration with academia was also presented at the 37 ECNP conference BUDAPEST, Hungary, Sept. 25, 2024 /PRNewswire ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of ...

AbbVie has entered a collaboration with Hungary-based pharmaceutical company Gedeon Richter to develop new treatments for neuropsychiatric conditions. The agreement focuses on discovering, co ...

DelveInsight's Rheumatoid Arthritis Pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. This ...

AbbVie and Gedeon Richter announced a new collaboration to discover and develop novel targets for neuropsychiatric conditions. According to AbbVie, the new license agreement will expand upon close to ...

See the latest Chemical Works of Gedeon Richter PLC stock price (RICHTER:XBUD), related news, valuation, dividends and more to help you make your investing decisions.

Access Gedeon Richter stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

The "Gedeon Richter House of Hope" was implemented by the Hungary-based Close to Africa Foundation in cooperation with its local partner, the Sini Sanuman Foundation.Richter covered a substantial ...

Gedeon Richter Plc. ( www.gedeonrichter.com ), headquartered in Budapest/Hungary , is a major pharmaceutical company in Central Eastern Europe , with an expanding direct presence in Western Europe ...

BUDAPEST, Hungary, May 6, 2025 /PRNewswire/ -- A center providing healthcare and educational support as well as shelter for vulnerable women has been built in Bamako, the capital of Mali, with ...